LYN and acute leukemia: In human diseases, Lyn is involved in treatment resistance and progression of chronic myeloid leukemia [9], its decrease affects BCR signalling in systemic lupus erythematosus [10] and also chronic and acute leukemia subtypes showed aberrations of Lyn expression [11].